Crocetin Enhances Temozolomide Efficacy in Glioblastoma Therapy Through Multiple Pathway Suppression

被引:0
|
作者
Tsai, Wei-En [1 ]
Liu, Yen-Tsen [1 ]
Kuo, Fu-Hsuan [2 ]
Cheng, Wen-Yu [3 ,4 ,5 ,6 ]
Shen, Chiung-Chyi [3 ,4 ,7 ]
Chiao, Ming-Tsang [3 ]
Huang, Yu-Fen [3 ]
Liang, Yea-Jiuen [3 ]
Yang, Yi-Chin [3 ]
Hsieh, Wan-Yu [3 ]
Chen, Jun-Peng [8 ]
Liu, Szu-Yuan [9 ,10 ]
Chiu, Cheng-Di [11 ,12 ]
机构
[1] Taichung Municipal Taichung First Sr High Sch, Taichung, Taiwan
[2] Taichung Vet Hosp, Ctr Geriatr & Gerontol, Taichung 40705, Taiwan
[3] Taichung Vet Gen Hosp, Neurol Inst, Dept Minimally Invas Skull Base Neurosurg, Taichung, Taiwan
[4] Hung Kuang Univ, Dept Phys Therapy, Taichung, Taiwan
[5] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan
[6] Natl Chung Hsing Univ, Coll Med, Dept Postbaccalaureate Med, Taichung, Taiwan
[7] Cent Taiwan Univ Sci & Technol, Basic Med Educ, Taichung, Taiwan
[8] Taichung Vet Gen Hosp, Biostat Task Force, Taichung, Taiwan
[9] Taichung Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Oncol Neurosurg Div, Taichung, Taiwan
[10] Natl Chung Hsing Univ, Grad Inst Life Sci, Coll Life Sci, Dept Life Sci, Taichung, Taiwan
[11] China Med Univ Hosp, Spine Ctr, Taichung, Taiwan
[12] China Med Univ Hosp, Dept Neurosurg, Taichung, Taiwan
关键词
Crocetin; glioblastoma; temozolomide; AKT signaling; cell migration; ACTIVATED PROTEIN-KINASES; MOBILITY GROUP BOX-1; CROCUS-SATIVUS; CELL-MIGRATION; CANCER-CELLS; ENDOTHELIAL-CELLS; GLIOMA CANCER; APOPTOSIS; GROWTH; METASTASIS;
D O I
10.2174/0115672026332275240731054001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Glioblastoma multiforme (GBM) is an aggressive type of braintumor that is difficult to remove surgically. Research suggests that substances from saffron, namely crocetin and crocin, could be effective natural treatments, showing abilities to kill cancer cells. Methods Our study focused on evaluating the effects of crocetin on glioma using the U87 cell line. We specifically investigated how crocetin affects the survival, growth, and spread of glioma cells, exploring its impact at concentrations ranging from 75-150 mu M. The study also included experiments combining crocetin with the chemotherapy drug Temozolomide (TMZ) to assess potential synergistic effects. Results Crocetin significantly reduced the viability, proliferation, and migration of glioma cells. It achieved these effects by decreasing the levels of Matrix Metallopeptidase 9 (MMP-9) and Ras homolog family member A (RhoA), proteins that are critical for cancer progression. Additionally, crocetin inhibited the formation of cellular structures necessary for tumor growth. It blocked multiple points of the Ak Strain Transforming (AKT) signaling pathway, which is vital for cancer cell survival. This treatment led to increased cell death and disrupted the cell cycle in the glioma cells. When used in combination with TMZ, crocetin not only enhanced the reduction of cancer cell growth but also promoted cell death and reduced cell replication. This combination therapy further decreased levels of high mobility group box 1 (HMGB1) and Receptor for Advanced Glycation End-products (RAGE), proteins linked to inflammation and tumor progression. It selectively inhibited certain pathways involved in the cellular stress response without affecting others. Conclusion Our results underscore the potential of crocetin as a treatment for glioma. It targets various mechanisms involved in tumor growth and spread, offering multiple avenues for therapy. Further studies are essential to fully understand and utilize crocetin's benefits in treating glioma.
引用
收藏
页码:320 / 336
页数:17
相关论文
共 50 条
  • [31] Ruxolitinib enhances cytotoxic and apoptotic effects of temozolomide on glioblastoma cells by regulating WNT signaling pathway-related genes
    Bakiye Goker Bagca
    Neslihan Pinar Ozates
    Cigir Biray Avci
    Medical Oncology, 40
  • [32] Mangiferin enhances the sensitivity of human multiple myeloma cells to anticancer drugs through suppression of the nuclear factor κB pathway
    Takeda, Tomoya
    Tsubaki, Masanobu
    Kino, Toshiki
    Kawamura, Ayako
    Isoyama, Shota
    Itoh, Tatsuki
    Imano, Motohiro
    Tanabe, Genzoh
    Muraoka, Osamu
    Matsuda, Hideaki
    Satou, Takao
    Nishida, Shozo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (06) : 2704 - 2712
  • [33] INDUCTION OF THE ASTROCYTIC LINEAGE PATHWAY SELECTIVELY ENHANCES THE CHEMOTHERAPEUTIC POTENTIAL OF TEMOZOLOMIDE AND CLOMIPRAMINE IN STEM-CELL ENRICHED GLIOBLASTOMA
    Donovan, Laura
    Birks, Suzanne
    Eason, Amy
    Bosak, Viktoria
    Pilkington, Geoffrey
    NEURO-ONCOLOGY, 2012, 14 : 1 - 1
  • [34] MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway
    Xu, Peng
    Zhang, Guofeng
    Hou, Shuangxing
    Sha, Long-gui
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 106 : 1419 - 1427
  • [35] Tonabersat enhances temozolomide-mediated cytotoxicity in glioblastoma by disrupting intercellular connectivity through connexin 43 inhibition
    Schmidt, Elena N. C.
    Evert, Bernd O.
    Pregler, Barbara E. F.
    Melhem, Ahmad
    Hsieh, Meng-Chun
    Raspe, Markus
    Strobel, Hannah
    Roos, Julian
    Pietsch, Torsten
    Schuss, Patrick
    Fischer-Posovszky, Pamela
    Westhoff, Mike-Andrew
    Hoelzel, Michael
    Herrlinger, Ulrich
    Vatter, Hartmut
    Waha, Andreas
    Schneider, Matthias
    Potthoff, Anna-Laura
    MOLECULAR ONCOLOGY, 2025, 19 (03) : 878 - 898
  • [36] Smurf1 Suppression Enhances Temozolomide Chemosensitivity in Glioblastoma by Facilitating PTEN Nuclear Translocation (vol 11, 3302, 2022)
    Dong, Lei
    Li, Yang
    Liu, Liqun
    Meng, Xinyi
    Li, Shengzhen
    Han, Da
    Xiao, Zhenyu
    Xia, Qin
    CELLS, 2024, 13 (18)
  • [37] Granulocyte-macrophage colony stimulating factor enhances efficacy of nimustine rendezvousing with temozolomide plus irradiation in patients with glioblastoma
    Yang, Dong-Yi
    Cheng, Xue
    Bu, Xing-Yao
    Yan, Zhao-Yue
    Qu, Ming-Qi
    Zhao, Yue-Wu
    Kong, Ling-Fei
    Wang, Yao-Wei
    Luo, Jian-Chao
    TECHNOLOGY AND HEALTH CARE, 2023, 31 (02) : 635 - 645
  • [38] CDH2 expression is of prognostic significance in glioma and predicts the efficacy of temozolomide therapy in patients with glioblastoma
    Chen, Qun
    Cai, Jinquan
    Jiang, Chuanlu
    ONCOLOGY LETTERS, 2018, 15 (05) : 7415 - 7422
  • [39] XAF1 enhances temozolomide induced autophagic cell death through AMPK signaling pathway
    Lee, M.
    Ko, K-P.
    Chi, S-G.
    ANNALS OF ONCOLOGY, 2019, 30
  • [40] INDUCTION OF THE ASTROCYTIC LINEAGE PATHWAY SELECTIVELY ENHANCES THE CHEMOTHERAPEUTIC POTENTIAL OF TEMOZOLOMIDE AND CLOMIPRAMINE IN STEM-CELL ENRICHED PAEDIATRIC GLIOBLASTOMA
    Donovan, Laura
    Birks, Suzanne
    Grunewald, Laura
    Zmuda, Filip
    Pilkington, Geoffrey
    NEURO-ONCOLOGY, 2013, 15 : 1 - 1